{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:40:31Z","timestamp":1792658431353,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":937,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA53840"],"award-info":[{"award-number":["CA53840"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM55989"],"award-info":[{"award-number":["GM55989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1074\/jbc.c117.819110","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T20:15:14Z","timestamp":1512677714000},"page":"1517-1525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models"],"prefix":"10.1016","volume":"293","author":[{"given":"Navasona","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantis F.","family":"Konidaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.C117.819110_bib1","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1046\/j.0014-2956.2001.02473.x","article-title":"The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture","volume":"268","author":"Cohen","year":"2001","journal-title":"Eur. J. Biochem"},{"key":"10.1074\/jbc.C117.819110_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/febs.12077","article-title":"Protein-tyrosine phosphatases\u2013from housekeeping enzymes to master regulators of signal transduction","volume":"280","author":"Tonks","year":"2013","journal-title":"FEBS J"},{"key":"10.1074\/jbc.C117.819110_bib3","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI76094","article-title":"Targeting cancer with kinase inhibitors","volume":"125","author":"Gross","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.C117.819110_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2017.03.004","article-title":"Targeting tyrosine phosphatases: time to end the stigma","volume":"38","author":"Stanford","year":"2017","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1074\/jbc.C117.819110_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/10409238.2013.819830","article-title":"PTP1B: a simple enzyme for a complex world","volume":"48","author":"Feldhammer","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol"},{"key":"10.1074\/jbc.C117.819110_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein-tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1074\/jbc.C117.819110_bib7","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","article-title":"Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice","volume":"20","author":"Klaman","year":"2000","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.C117.819110_bib8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/aps.2014.80","article-title":"Protein-tyrosine phosphatases as potential therapeutic targets","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol. Sin"},{"key":"10.1074\/jbc.C117.819110_bib9","article-title":"Recent advances in protein tyrosine phosphatase 1B targeted drug discovery for Type II diabetes and obesity","author":"Maheswari","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1074\/jbc.C117.819110_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nchembio.1528","article-title":"Targeting the disordered C terminus of PTP1B with an allosteric inhibitor","volume":"10","author":"Krishnan","year":"2014","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.C117.819110_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cell.2011.08.036","article-title":"Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity","volume":"147","author":"Haque","year":"2011","journal-title":"Cell"},{"key":"10.1074\/jbc.C117.819110_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymeth.2013.08.013","article-title":"Integrating virtual and biochemical screening for protein-tyrosine phosphatase inhibitor discovery","volume":"65","author":"Martin","year":"2014","journal-title":"Methods"},{"key":"10.1074\/jbc.C117.819110_bib13","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/cr900134a","article-title":"Application of metal coordination chemistry to explore and manipulate cell biology","volume":"109","author":"Haas","year":"2009","journal-title":"Chem. Rev"},{"key":"10.1074\/jbc.C117.819110_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jinorgbio.2011.11.024","article-title":"Coordination chemistry of copper proteins: how nature handles a toxic cargo for essential function","volume":"107","author":"Rubino","year":"2012","journal-title":"J. Inorg. Biochem"},{"key":"10.1074\/jbc.C117.819110_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1534-5807(02)00148-X","article-title":"PTP1B regulates leptin signal transduction in vivo","volume":"2","author":"Zabolotny","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.C117.819110_bib16","doi-asserted-by":"crossref","first-page":"47771","DOI":"10.1074\/jbc.C100583200","article-title":"TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B","volume":"276","author":"Myers","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.C117.819110_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0974-9233.154385","article-title":"Diabetic retinopathy: a global epidemic","volume":"22","author":"Das","year":"2015","journal-title":"Middle East Afr. J. Ophthalmol"},{"key":"10.1074\/jbc.C117.819110_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4239\/wjd.v7.i17.354","article-title":"Update on the treatment of type 2 diabetes mellitus","volume":"7","author":"Marn-Pe\u00f1alver","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1074\/jbc.C117.819110_bib19","first-page":"458","article-title":"Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes","volume":"10","author":"Tonks","year":"1990","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.C117.819110_bib20","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.87.14.5514","article-title":"Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes","volume":"87","author":"Cicirelli","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.C117.819110_bib21","doi-asserted-by":"crossref","first-page":"926857","DOI":"10.1155\/2012\/926857","article-title":"The genetics of PTPN1 and obesity: insights from mouse models of tissue-specific PTP1B deficiency","volume":"2012","author":"Tsou","year":"2012","journal-title":"J. Obes"},{"key":"10.1074\/jbc.C117.819110_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1534-5807(02)00149-1","article-title":"Attenuation of leptin action and regulation of obesity by protein-tyrosine phosphatase 1B","volume":"2","author":"Cheng","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.C117.819110_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrd895","article-title":"Protein-tyrosine phosphatase 1B inhibitors for diabetes","volume":"1","author":"Johnson","year":"2002","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.C117.819110_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1074\/jbc.C117.819110_bib25","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/S0021-9258(19)69016-2","article-title":"Phosphotyrosyl-protein phosphatase: Specific inhibition by Zn","volume":"256","author":"Brautigan","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1074\/jbc.C117.819110_bib26","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/bi00265a030","article-title":"Partial purification and characterization of phosphotyrosyl-protein phosphatse from Ehrlich ascites tumor cells","volume":"21","author":"H\u00f6rlein","year":"1982","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.C117.819110_bib27","doi-asserted-by":"crossref","first-page":"11675","DOI":"10.1039\/c1dt10380f","article-title":"Metal-based anti-diabetic drugs: advances and challenges","volume":"40","author":"Levina","year":"2011","journal-title":"Dalton Trans"},{"key":"10.1074\/jbc.C117.819110_bib28","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1089\/ars.2013.5720","article-title":"Protein-tyrosine phosphatase inhibition by metals and metal complexes","volume":"20","author":"Lu","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.C117.819110_bib29","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev"},{"key":"10.1074\/jbc.C117.819110_bib30","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1039\/b705551j","article-title":"Metal based drugs: from serendipity to design","volume":"43","author":"Fricker","year":"2007","journal-title":"Dalton Trans"},{"key":"10.1074\/jbc.C117.819110_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1039\/b813568a","article-title":"Targeting proteins with metal complexes","volume":"9","author":"Meggers","year":"2009","journal-title":"Chem. Commun"},{"key":"10.1074\/jbc.C117.819110_bib32","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm00086a020","article-title":"Bis(maltolato)oxovanadium(IV) is a potent insulin mimic","volume":"35","author":"McNeill","year":"1992","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.C117.819110_bib33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.3156405","article-title":"Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats","volume":"227","author":"Heyliger","year":"1985","journal-title":"Science"},{"key":"10.1074\/jbc.C117.819110_bib34","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1039\/b803261k","article-title":"A potential role for protein-tyrosine phosphatase inhibition by a RuIII-edta complex (edta = ethylenediaminetetraacetate) in its biological activity","volume":"25","author":"Chatterjee","year":"2008","journal-title":"Chem. Commun"},{"key":"10.1074\/jbc.C117.819110_bib35","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/jm800101w","article-title":"Gold(I)-mediated inhibition of protein-tyrosine phosphatases: a detailed in vitro and cellular study","volume":"51","author":"Krishnamurthy","year":"2008","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.C117.819110_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/JAD-161033","article-title":"Diabetes and Alzheimer's disease: can elevated free copper predict the risk of the disease?","volume":"56","author":"Squitti","year":"2017","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.C117.819110_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1507\/endocrj.K09E-051","article-title":"Role of copper ion in the pathogenesis of type 2 diabetes","volume":"56","author":"Tanaka","year":"2009","journal-title":"Endocr. J"},{"key":"10.1074\/jbc.C117.819110_bib38","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.2174\/092986712800609715","article-title":"Selective divalent copper chelation for the treatment of diabetes mellitus","volume":"19","author":"Cooper","year":"2012","journal-title":"Curr. Med. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820389316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820389316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.C117.819110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T09:40:39Z","timestamp":1641289239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820389316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0021925820389316"],"URL":"https:\/\/doi.org\/10.1074\/jbc.c117.819110","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.C117.819110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Biochemistry and Molecular Biology, Inc.","name":"copyright","label":"Copyright"}]}}